These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23726612)

  • 1. Antithymocyte globulin induction and rapid steroid taper leads to excellent results in kidney transplantation with donation after cardiac death donors: importance of rejection and delayed graft function.
    Mai ML; Mai WK; Taner CB; Prendergast MB; Wadei HM; Gonwa TA
    Transplant Proc; 2013 May; 45(4):1528-30. PubMed ID: 23726612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of delayed graft function and acute rejection on outcomes after kidney transplantation from donors after cardiac death.
    Nagaraja P; Roberts GW; Stephens M; Horvath S; Fialova J; Chavez R; Asderakis A; Kaposztas Z
    Transplantation; 2012 Dec; 94(12):1218-23. PubMed ID: 23154212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes.
    Singh RP; Farney AC; Rogers J; Zuckerman J; Reeves-Daniel A; Hartmann E; Iskandar S; Adams P; Stratta RJ
    Clin Transplant; 2011; 25(2):255-64. PubMed ID: 20331689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation.
    Wadei HM; Heckman MG; Rawal B; Taner CB; Farahat W; Nur L; Mai ML; Prendergast M; Gonwa TA
    Transplantation; 2013 Aug; 96(3):274-81. PubMed ID: 23778649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses.
    Wadei HM; Bulatao IG; Gonwa TA; Mai ML; Prendergast M; Keaveny AP; Rosser BG; Taner CB
    Liver Transpl; 2014 Jun; 20(6):728-35. PubMed ID: 24648186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed graft function does not harm the future of donation-after-cardiac death in kidney transplantation.
    Le Dinh H; Weekers L; Bonvoisin C; Krzesinski JM; Monard J; de Roover A; Squifflet JP; Meurisse M; Detry O
    Transplant Proc; 2012 Nov; 44(9):2795-802. PubMed ID: 23146527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of kidneys from paediatric DCD donors: a comparison with DBD donors.
    de Vries EE; Hoogland PE; Wind J; Snoeijs MG; van Heurn EL
    Nephrol Dial Transplant; 2013 Jan; 28(1):220-6. PubMed ID: 23197676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplantation from donors after brain or cardiac death in China--a clinical analysis of 94 cases.
    Wang C; Liu L; Fu Q; Meng F; Li J; Deng S; Fei J; Yuan X; Han M; Chen L; Qiu J; Chen G; Wang H; Huo F; Li J; Lin M; He X
    Transplant Proc; 2013 May; 45(4):1323-6. PubMed ID: 23726563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of expanded criteria variables on outcomes of kidney transplantation from donors after cardiac death.
    Nagaraja P; Roberts GW; Stephens M; Horvath S; Kaposztas Z; Chavez R; Asderakis A
    Transplantation; 2015 Jan; 99(1):226-31. PubMed ID: 25099703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.
    Saull HE; Enderby CY; Gonwa TA; Wadei HM
    Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support.
    Farney AC; Singh RP; Hines MH; Rogers J; Hartmann EL; Reeves-Daniel A; Gautreaux MD; Iskandar SS; Adams PL; Stratta RJ
    J Am Coll Surg; 2008 May; 206(5):1028-37; discussion 1037. PubMed ID: 18471749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI.
    Sánchez-Escuredo A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Peri L; Ruiz Á; Campistol JM; Oppenheimer F
    Transpl Int; 2016 Mar; 29(3):362-8. PubMed ID: 26678359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor kidney disease and transplant outcome for kidneys donated after cardiac death.
    Wells AC; Rushworth L; Thiru S; Sharples L; Watson CJ; Bradley JA; Pettigrew GJ
    Br J Surg; 2009 Mar; 96(3):299-304. PubMed ID: 19224513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysis.
    Zens TJ; Danobeitia JS; Leverson G; Chlebeck PJ; Zitur LJ; Redfield RR; D'Alessandro AM; Odorico S; Kaufman DB; Fernandez LA
    Clin Transplant; 2018 Mar; 32(3):e13190. PubMed ID: 29314286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donation after cardiac death: the University of Wisconsin experience.
    D'Alessandro AM; Fernandez LA; Chin LT; Shames BD; Turgeon NA; Scott DL; Di Carlo A; Becker YT; Odorico JS; Knechtle SJ; Love RB; Pirsch JD; Becker BN; Musat AI; Kalayoglu M; Sollinger HW
    Ann Transplant; 2004; 9(1):68-71. PubMed ID: 15478896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death.
    Schadde E; D'Alessandro AM; Knechtle SJ; Odorico J; Becker Y; Pirsch J; Sollinger H; Fernandez LA
    Transpl Int; 2008 Jul; 21(7):625-36. PubMed ID: 18397178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More donors or more delayed graft function? A cost-effectiveness analysis of DCD kidney transplantation.
    Snyder RA; Moore DR; Moore DE
    Clin Transplant; 2013; 27(2):289-96. PubMed ID: 23350938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of kidney transplantation from elderly donors after cardiac death.
    Thornton SR; Hamilton N; Evans D; Fleming T; Clarke E; Morgan J; Kadi N
    Transplant Proc; 2011 Dec; 43(10):3686-9. PubMed ID: 22172826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.